GlobeNewswire Inc.·3h ago·NaHemab Therapeutics Prices $301.5M IPO at $18/Share, Nasdaq Debut Set for MayHemab Therapeutics prices $301.5M IPO at $18/share, listing on Nasdaq as $COAG starting May 1, 2026. JEFEVRIPOclinical-stage
GlobeNewswire Inc.··Na